BioNTech SE is a global biotechnology company headquartered in Mainz, Germany, that develops and manufactures mRNA-based immunotherapies and vaccines. While primarily a pharmaceutical innovator, BioNTech operates extensive in-house GMP manufacturing capabilities for mRNA, antibodies, and cell therapies across multiple global sites. They pioneered the BioNTainer modular mRNA manufacturing solution. FDA-registered for API manufacture and analysis. Active in 10+ clinical trials across oncology and infectious disease.
mRNA platform, cancer immunotherapy, mRNA vaccine manufacturing, plasmid DNA manufacturing, antibody manufacturing, AI-driven drug discovery, modular manufacturing (BioNTainer)
1 site worldwide
Involvement in 10 clinical trials
No reviews available yet.
No documents available.